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Imaging genomics is an emerging research field, where integrative analysis of imaging and omics data
is performed to provide new insights into the phenotypic characteristics and genetic mechanisms of
normal and/or disordered biological structures and functions, and to impact the development of
new diagnostic, therapeutic and preventive approaches. The Imaging Genomics Session at PSB 2017
aims to encourage discussion on fundamental concepts, new methods and innovative applications in
this young and rapidly evolving field.
1. Introduction
Imaging genomics1–9 is an emerging research field that arises with the recent advances in
acquiring high throughput omics data and multimodal imaging data. Its major task is to
perform integrative analysis of genomics data and structural, functional and molecular imaging
data. Bridging imaging and genomic factors and exploring their connections have the potential
to provide important new insights into the phenotypic characteristics and genetic mechanisms
of normal and/or disordered biological structures and functions, which in turn will impact the
development of new diagnostic, therapeutic and preventive approaches.
Binformatics strategies for imaging genomics, which is a relatively young field,1–4 have
been rapidly evolving. Early studies started with the simplest strategy to examine pairwise
univariate associations10,11 between genetic markers and imaging phenotypes. To identify more
flexible associations involving multiple genetic markers and multiple imaging phenotypes,
recent studies employed multiple regression and multivariate models,12 sometimes coupled with
powerful machine learning approaches13 and valuable prior knowledge14 to discover relevant
imaging and genomic features. To increase statistical power and reduce false positives, meta-
analysis studies15,16 were performed to quantitatively synthesize imaging genomic findings
from multiple independent analyses. To hunt for “missing heritability”, epistatic studies17
were performed to examine genetic interaction effects on imaging phenotypes. To identify
biologically meaningful findings with increased statistical power, imaging genetic enrichment
analysis18 was proposed to mine set level associations in both imaging and genomic domains.
The topic of imaging genomics has recently been addressed in several medical imaging
and bioinformatics conferences. The most focused one is the International Imaging Genetics





























































































Conference (IIGC, http://www.imaginggenetics.uci.edu/), which is an annual meeting orga-
nized at the UC Irvine since 2005. The MICCAI Workshop on Imaging Genetics (MICGen,
http://micgen.csail.mit.edu/) has been held twice in conjunction with the major medical im-
age computing conference MICCAI in 2014 and 2015. An educational course on “Introduction
to Imaging Genetics” has been offered at the annual meeting of the Organization for Human
Brain Mapping (OHBM) since 2009. The topic of imaging genomics has also been covered in
the following two events in the bioinformatics field: (1) ACM BCB 2015 Workshop on The
Computational Pathology: Linking Tissue Phenotypes with Genomics and Clinical Outcomes,
and (2) ICIBM 2015 Tutorial in Bioimage Informatics and Integrative Genomics.
As the field of imaging genomics contains a significant genomics (or omics in general) com-
ponent in addition to biomedical imaging, we feel that it is timely for a major bioinformatics
conference such as PSB to address this important, relevant and emerging topic. We believe
that PSB offers an ideal and timely opportunity to bring together people with different exper-
tise and shared interests in this rapidly evolving field. Specifically, the computational biology
and bioinformatics expertise of the PSB and ISCB communities can provide important new
perspective, complementary to the expertise of the IIGC, MICCAI, OHBM, ACM BCB and
ICIBM communities, and thus can help contribute new concepts, methods, and applications
to the analysis of emerging imaging and genomic data.
The scale and complexity of multidimensional imaging and omics data provide us un-
precedented opportunities in enhancing mechanistic understanding of complex disorders such
as neurological diseases19–21 and cancers,22,23 which can benefit public health outcomes by
facilitating diagnostic and therapeutic progress. However, due to the extremely high dimen-
sionality and complex structure of these data sets, this field is facing major computational and
bioinformatics challenges. The technological advance in this field is urgently needed and has
the potential to significantly contribute to multiple national health priority areas including
the Precision Medicine Initiative,24 the Brain Initiative,25 and the Big Data to Knowledge
Initiative.26
The objective of this Imaging Genomics Session at PSB 2017 is to encourage discussion on
fundamental concepts, novel methods and innovative applications. We hope that this session
will become a forum for researchers to exchange ideas, data, and software, in order to speed up
the development of innovative technologies for hypothesis testing and data-driven discovery
in Imaging Genomics.
2. Session Summary
This session includes an invited lecture and five accepted presentations with peer-reviewed
papers. Three presentations will be delivered as platform talks and the other two as posters.
2.1. Invited Talk
Our invited lecture will be given by Dr. Paul Thompson, a world renowned pioneer in imag-
ing genomics. Dr. Thompson is from the University of Southern California (USC). At USC,
he is a Professor of Neurology, Psychiatry, Radiology, Pediatrics, Engineering, and Ophthal-
mology, the director of the USC Imaging Genetics Center, and the director of the ENIGMA





























































































Center for Worldwide Medicine, Imaging & Genomics – an $11M NIH Center of Excellence
in Big Data Computing. Dr. Thompson’s major contributions to the field of imaging ge-
nomics and to the science in general can be summarized by the following text quoted from
http://keck.usc.edu/faculty/paul-m-thompson/:
Paul Thompson directs the ENIGMA Consortium, a global alliance of 307 scien-
tists in 33 countries who conduct the largest studies of 10 major brain diseases –
ranging from schizophrenia, depression, ADHD, bipolar illness and OCD, to HIV
and addictions on the brain. ENIGMA’s genomic screens of over 31,000 people’s
brain scans and genome-wide data (published in Nature Genetics, 2012; Nature,
2015) have brought together experts from 185 institutions to unearth genetic
variants that affect brain structure, disease risk, and brain connectivity. Collabo-
rating with imaging labs around the world, Dr. Thompson and his students have
published over 1,300 publications (h-index: 116) describing novel mathematical
and computational strategies for analyzing brain image databases, for detecting
pathology in individual patients and groups, and for creating disease-specific
atlases of the human brain.
2.2. Papers
In Integrative analysis for lung adenocarcinoma predicts morphological features associated with
genetic variations, Wang et al. analyzed an imaging genomic data set downloaded from the
TCGA portal, containing 201 patients with lung adenocarcinoma (LUAD). The data includes
clinical information, mRNA expression profiles, and histopathologic whole slide images of
the patients. On the imaging end, the authors calculated 283 morphological features from
histopathologic images, and identified features strongly correlated with patient survival out-
come. On the genomic end, the authors constructed the gene co-expression network and ex-
tracted gene co-expression clusters. To relate imaging with genomics, the authors regressed the
outcome-relevant morphological feature on multiple co-expressed gene clusters using Lasso.
The study identified gene clusters highly associated with DNA copy number variations. These
observations may lead to new insight on lung cancer development, suggesting biological path-
ways from genetic variations, gene transcription, cancer morphology to survival outcome.
In Identification of discriminative imaging proteomics associations in Alzheimer’s disease
via a novel sparse canonical correlation model, Yan et al. analyzed an imaging proteomic
data set downloaded from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database.
Participants include 42 healthy controls, 67 patients with mild cognitive impairment (MCI),
and 67 patients with Alzheimer’s disease (AD). The data includes clinical information, mag-
netic resonance imaging (MRI) scans, and expression data of 229 proteomic analytes (83 from
cerebrospinal fluid and 146 from plasma). The authors developed a novel machine learning
model, called discriminative sparse canonical correlation analysis (DSCCA), and applied it to
the joint analysis of imaging, proteomic and diagnostic data. This analysis yielded a strong
imaging proteomic association so that the identified imaging and proteomic components had
also high discriminative power. Such an outcome-relevant imaging proteomic pattern has the
potential to improve mechanistic understanding of the disease.





























































































In Enforcing co-expression in multimodal regression framework, Zille et al. analyzed an
imaging genomic data set collected by Mind Clinical Imaging Consortium (MCIC). Partic-
ipants include 116 controls and 92 schizophrenia patients. The data includes clinical infor-
mation, functional MRI (fMRI) scans, and genotyping data. The authors developed a new
machine learning model, called MT-CoReg, by combining sparse regression with canonical
correlation analysis; and applied it to the analysis of the MCIC data. The analysis identified
imaging and genomic markers that not only induce a strong imaging genomic association but
also can jointly predict the outcome.
In Adaptive testing of SNP-brain functional connectivity association via a modular net-
work analysis, Gao et al. analyzed an imaging genomic data set downloaded from the ADNI
database. Participants include 162 ADNI subjects: 73 with no APOE E4 allele, 67 with one
copy of the APOE E4 allele, and 22 with two copies of the APOE E4 allele. The authors ana-
lyzed the resting-state fMRI data to identify modular structures in brain functional networks,
using a weighted gene co-expression network analysis (WGCNA) framework, coupled with
topological overlap matrix (TOM) elements in hierarchical clustering. After that, they em-
ployed an adaptive association test based on the proportional odds model to identify distinct
modular structures in brain functional networks in relation to different APOE E4 groups.
In Exploring brain transcriptomic patterns: a topological analysis using spatial expression
networks, Kuncheva et al. analyzed whole genome whole brain gene expression data down-
loaded from the Allen Human Brain Atlas (AHBA). Participants include six AHBA donors.
The authors focused on 16,906 genes selected based on a previous study, and 105 brain regions
where at least one measurement in all 6 brains were available. A Spatial Expression Network
(SEN) was extracted for each gene to quantify co-expression patterns amongst several anatom-
ical locations. After that, network similarity measures were computed and used to quantify
the topological resemblance between pairs of SENs and identify naturally occurring clusters.
The analysis identified three stable clusters, including one with genes specifically involved in
the nervous system, and the other two representing immunity, transcription and translation.
2.3. Discussion
Most of these studies were facilitated by and conducted using the Big Data resources available
in the open science domain, including TCGA analyzed in (Wang et al.), ADNI analyzed in
(Yan et al. & Gao et al.), and AHBA analyzed in (Kuncheva et al.). The imaging data
investigated by these studies ranged from histological whole slide images of cancer specimens
in (Wang et al.), structural MRI scans in (Yan et al.), functional MRI scans in (Zille et al.
& Gao et al.), to images of mRNA expression levels across the brain in (Kuncheva et al.).
The omics data examined in these studies were also diverse, including DNA genotyping data
in (Zille et al. & Gao et al.), mRNA expression profiles in (Wang et al. & Kuncheva et
al.), and proteomic expression profiles in (Yan et al.).
These studies were performed to better understand the brain transcriptomic patterns in
healthy controls (Kuncheva et al.), the brain imaging genomic or imaging proteomic patterns
in Alzheimer’s disease (Yan et al. & Gao et al.) or schizophrenia (Zille et al.), and biolog-
ical pathways from gene transcription, tissue morphology to survival outcome in lung cancer





























































































(Wang et al.). As to the bioinformatics strategies, a variety of machine learning methods
were employed or newly developed in these studies, including network analysis and clustering
models used in (Wang et al., Gao et al. & Kuncheva et al.), regression models used in
(Wang et al.), an adaptive association test used in (Gao et al.), an integrative regression
and canonical correlation analysis model used in (Zille et al.), and an outcome-regularized
sparse canonical correlation analysis model used in (Yan et al.).
While Gao et al. studied functional brain network as an innovative imaging phenotype,
Kuncheva et al. aimed to identify gene clusters using whole brain spatial expression net-
works. The remaining three studies (Wang et al., Yan et al. & Zille et al.) shared a
common theme to examine the relationship among three levels (i.e., omics features, imaging
phenotypes, and clinical outcomes). This suggests a promising future direction to integrate
imaging genomics with systems biology, which attempts to model complex and interactive
multilevel biological systems using multimodal imaging and multidimensional omics data sets.
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